Gene therapy for hemophilia B represents a groundbreaking advancement in hemophilia B treatment, offering newfound hope for those living with the condition.Hemgenix, the innovative gene therapy recently approved by the FDA, aims to address the underlying genetic causes of this bleeding disorder, reducing the need for chronic clotting factor infusions.